Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $12.09M.
ENTERPRISE VALUE (EV)
$12.09M
iBio, Inc.
Market Cap
$68.49M
Enterprise Value (EV)
$12.09M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| iBio, Inc. (IBIO) | $68.49M | $12.09M |
| Fortress Biotech, Inc. (FBIO)vs › | $68.27M | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $69.31M | $66.35M |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | $20.75M |
| Champions Oncology, Inc. (CSBR)vs › | $70.30M | $76.91M |
| Cingulate Inc. (CING)vs › | $65.86M | $43.75M |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.32M | $63.28M |
| RenovoRx, Inc. (RNXT)vs › | $64.88M | $55.66M |
| Gain Therapeutics, Inc. (GANX)vs › | $72.30M | $59.82M |
Market Cap
$68.49M
Total Debt
$0.00
Cash
$56.40M
Enterprise Value
$12.09M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
